Programme
09:15 - 09:30
Registration
16:00 - 18:30
Champalimaud Auditorium
Complex Pancreatic Cancer Surgery
Cancer Systems and spatial approaches
Coffee Break
World Pancreas Forum (WPF)*
Vision of Champalimaud Foundation
Clinical applications for molecular subtypes
Complication Management in Pancreatic Surgery
Lunch
09:15 - 09:30
Registration
08:00 - 18:30
Champalimaud Auditorium & Botton-Champalimaud Pancreatic Cancer Centre
09:15 - 09:30
Welcome Introduction
08:30 - 09:00
Champalimaud Auditorium
- Leonor Beleza, President of the Champalimaud Foundation, Lisbon, Portugal
- João Silveira Botelho, Vice-President of the Champalimaud Foundation, Lisbon, Portugal
- Peter Bailey, Director of Translational Research of the Botton-Champalimaud Pancreatic Cancer Centre, Lisbon, Portugal
- Markus Büchler, Director of the Botton-Champalimaud Pancreatic Cancer Centre, Lisbon, Portugal
09:15 - 09:30
Targeting PDAC
09:00 – 10:40
Champalimaud Auditorium
Chairs:
- Faiyaz Notta, Toronto, Canada
- Maximillian Reichert, Munich, Germany
- Dieter Sauer, Munich, Germany
- Andreas Trumpp, Heidelberg, Germany
09:00 - 09:20
Targeting KRAS-driven Pancreatic Cancer
Mariano Barbacid, Madrid, Spain
09:20 - 09:40
The effects of pan-RAS inhibition on models of pancreatic ductal adenocarcinoma
Kenneth Olive, Boston, USA
09:40 - 10:00
KRAS inhibitors: resistance mechanisms and combinations
Channing Der, North Carolina, USA
10:00 - 10:20
Targeting RAS in Pancreatic Cancer
Andrew Aguirre, Boston, USA
10:20 - 10:40
PRMT5: A Precision Therapeutic target for MTAP-Loss Pancreatic Tumors
Maxim Pimkin, Boston, USA
09:15 - 09:30
Radiology, Diagnostics and Artificial Intelligence
09:00 – 11:00
Botton Auditorium
Chairs:
- Stefano Crippa, Milan, Italy
- Kuirong Jiang, Nanjing, China
- Celso Matos, Lisbon, Portugal
- Christoph Springfeld, Heidelberg, Germany
09:00 - 09:20
Evidence-based Radiology
Carlos Bilreiro, Lisbon, Portugal
09:20 - 09:40
Radiology of the Pancreas: State of the Art
Gõtz Richter, Stuttgart, Germany
09:40 - 10:00
Radiology of Recurrence
Mark Wielpütz, Greifswald, Germany
10:00 - 10:20
Artificial Intelligence for Diagnosis
Dow-Mu Koh, London, UK
10:20 - 10:40
Interventional Radiology: Collections
Hugo Rio-Tinto, Lisbon, Portugal
10:40 - 11:00
Interventional Radiology: Bleeding
De-Hua Chang, Luzern, Switzerland
09:15 - 09:30
Coffee Break
10:40 - 11:30
09:15 - 09:30
Nanjing Campus 2025 - the new projects*
11:30 - 12:50
Botton Seminar Room
Chairs:
- Kuirong Jiang, Nanjing, China
- Yi Miao, Nanjing, China
Mentors:
- Jin He, Baltimore, USA
- Zipeng Lu, Nanjing, China
- Giovanni Marchegiani, Padova, Italy
- Jens Werner, Munich, Germany
- Christoph Wolfgang, New York, USA
11:30 - 11:40
Introduction
Yi Miao and Kuirong Jiang, Nanjing, China
11:40 - 11:50
The Nanjing Campus
Zipeng Lu, Nanjing, China
11:50 - 12:00
Prognostic Factors Based on Tumor Location (Head vs. Body/Tail) in the Era of Neoadjuvant Chemotherapy
Thomas Hank, Heidelberg, Germany
12:00 - 12:10
Multicentric RCT on the Use of Anticoagulation After Venous Resection
Filipe Borges, Lisbon, Portugal
12:10 - 12:20
Synthetic Allograft vs. Autologous Left Renal Vein for Venous Interposition – Proposal for a Randomized Controlled Multicenter Clinical Trial
Benedict Kinny-Köster, New York, USA
12:20 - 12:30
Postoperative Adjuvant Therapy and Optimization of Treatment Strategies in Pancreatic Cancer Patients Following Neoadjuvant Therapy
Yazhou Wang, Nanjing, China
12:30 - 12:40
Definition, Prediction and Treatment of Post-Pancreatectomy Liver Injury
Nicola Canitano, Padova, Italy
12:40 - 12:50
Comparative Analysis of Post-Pancreatic Surgical Complications in Elderly vs. Younger Patients with Small Inactive Neuroendocrine Pancreatic Tumors
Ughur Aghamaliyev, Munich, Germany
09:15 - 09:30
Invasion and Metastasis
11:30 - 13:10
Champalimaud Auditorium
Chairs:
- Anirbarn Maitra, New York, USA
- Kenneth Olive, Boston, USA
- Laura Soucek, Barcelona, Spain
- David Ting, Boston, USA
11:30 - 11:50
Insights into liver versuslung metastatic tropism in pancreatic ductal adenocarcinoma
Rosalie Sears, Portland, USA
11:50 - 12:10
Exploring metabolic pathways that promote metastatic pancreatic cancer
Sophie Vasseur, Marseille, France
12:10 - 12:30
Molecular and functional analysis of PDAC innervating neurons
Andreas Trumpp, Heidelberg, Germany
12:30 - 12:50
Lineage restricted evolutionary patterns in PDAC
Giannicola Genovese, Houston, USA
12:50 - 13:10
Tumor-Nerve Interactions in Pancreatic Cancer
William Hwang, Boston, USA
09:15 - 09:30
PanNET and other malignancies
11:30 - 13:30
Botton Auditorium
Chairs:
- Volkan Adsay, Istanbul, Turkey
- Ugo Boggi, Pisa, Italy
- Keith Lillemoe, Boston, USA
- Nuh Rahbari, Ulm, Germany
11:30 - 11:50
Is every PanNET malignant?
Pelin Bağci, Lisbon, Portugal
11:50 - 12:10
Radiology of PanNETs
Celso Matos, Lisbon, Portugal
12:10 - 12:30
PanNET: Surgical Experience with 800 Patients
Thomas Hank, Heidelberg, Germany
12:30 - 12:50
PanNET Debate: Watch and Wait
Alessandro Zerbi, Milan, Italy
12:50 - 13:10
PanNET Debate: Surgery
Marta Sousa, Lisbon, Portugal
13:10 - 13:30
Rare Pancreatic Neoplasms
Christoph Berchtold, Heidelberg, Germany
09:15 - 09:30
Lunch
12:30 - 14:00
09:15 - 09:30
Principles of Pancreatic Cancer Surgery
14:00 - 15:40
Champalimaud Auditorium
Chairs:
- Cristina Ferrone, Los Angeles, USA
- Helmut Friess, Munich, Germany
- Yi Miao, Nanjing, China
- Christopher Wolfgang, New York, USA
14:00 - 14:20
Surgery of Pancreatic Neuroendocrine Tumors
Richard Schulick, Denver, USA
14:20 - 14:40
Standards of oncological pancreatic head resection
Pierluigi Di Sebastiano, Pescara, Italy
14:40 - 15:00
Pancreatic anastomosis
Marisa Aral, Lisbon, Portugal
15:00 - 15:20
Artery-first approaches
Kuirong Jiang, Nanjing, China
15:20 - 15:40
Total pancreatectomy
Miguel Fróis Borges, Lisbon, Portugal
09:15 - 09:30
PDAC Tumour microenvironment (1)
14:00 - 16:00
Botton Auditorium
Chairs:
- Andrew Aguirre, Boston, USA
- Mariano Barbacid, Madrid, Spain
- Giannicola Genovese, Houston, USA
- Claus Jørgensen, Manchester, UK
14:00 - 14:20
Spatial proteomic maps of pancreatic cancer extend tumour subtype and microenvironment classifications
Hartland Jackson, Toronto, Canada
14:20 - 14:40
The Viral Basis of Pancreatic Cancer
David Ting, Boston, USA
14:40 - 15:00
Dissecting (onco)gene-environment interactions driving pancreatic cancer initiation
Direna Alonso-Curbelo, Barcelona, Spain
15:00 - 15:20
Extracting mechanisms of cell cross talk in pancreatic cancer using big data
Nina Steele, Cincinnati, USA
15:20 - 15:40
Decoding the plasticity of stroma during pancreatic cancer progression and chemoresistance
Corinne Bousquet, Toulouse, France
15:40 - 16:00
Detecting and Preventing Lethal Pancreatic Cancer
Anirban Maitra, New York, USA
09:15 - 09:30
Nursing in PC (1) A New Patient for Surgery: What Now?
14:00 - 16:00
Botton Seminar Room
Chair:
- António Parreira, Lisbon, Portugal
14:00 - 14:10
Mission Possible
Mariana Pinto, Lisbon, Portugal
14:10 - 14:30
Let’s Look Inside
Sofia Esteves, Lisbon, Portugal
14:30 - 14:45
ICU: Critical Recovery
Fernanda Conceição and Helena Freitas, Lisbon, Portugal
14:45 - 15:00
Hospitalization: Healing in Progress
Nuno Campos, Lisbon, Portugal
15:00 - 15:15
Finally at Home
Helena Lagartinho, Lisbon, Portugal
15:15 - 15:30
Pancreas Gone, Insulin ON
Inês Inocêncio, Lisbon, Portugal
15:30 - 16:00
Discussion
09:15 - 09:30
Coffee Break
15:40 - 16:30
09:15 - 09:30
Nursing in PC (2) More than a Surgery: How to Improve?
16:30 - 18:10
Botton Seminar Room
Chair:
- Hugo Reis, Lisbon, Portugal
16:30 - 16:50
International Patient: Please Fasten your Seatbelt
Lilia Coutinho, Lisbon, Portugal
16:50 - 17:10
Nutritional Challenges Following Pancreatectomy
Diana Alexandre, Lisbon, Portugal
17:10 - 17:30
Addressing the Psychological Needs of Pancreatic Cancer Patients
Tina Gustavell, Lisbon, Portugal
17:30 - 17:50
When the Body Betrays, the Mind Follows: The Dual Toll of Pancreatic Cancer
José Oliveira, Lisbon, Portugal
17:50 - 18:10
Patient Testimony
09:15 - 09:30
Surgery for Borderline / Locally Advanced PDAC
16:30 - 18:30
Champalimaud Auditorium
Chairs:
- Phillipe Bachellier, Strasbourg, France
- Volodomyr Kopchak, Kiev, Ukraine
- Pauli Puolakkainen, Helsinki, Finland
- Richard Schulik, Colorado, USA
16:30 - 16:50
Multivisceral Resection
Helmut Friess, Munich, Germany
16:50 - 17:10
Triangle Operation
Vera Oliveira, Lisbon, Portugal
17:10 - 17:30
Peri-Arterial Divestment
Yi Miao, Nanjing, China
17:30 - 17:50
DP-CARs (Appleby) Operation
Filipe Borges, Lisbon, Portugal
17:50 - 18:10
Venous Resection
Martin Schneider, Giessen, Germany
18:10 - 18:30
Surgical Treatment of PDAC Recurrence
Robert Grützmann, Erlangen, Germany
09:15 - 09:30
Early Detection, Liquid Biopsy and Artificial Intelligence
16:50 - 18:10
Botton Auditorium
Chairs:
- Carlos Carvalho, Lisbon, Portugal
- Jin He, Baltimore, USA
- Dirk Jäger, Heidelberg, Germany
- Grainne O’Kane, Dublin, Ireland
16:50 - 17:10
PRECEDE Consortium
Dianne Simeone, California, USA
17:10 - 17:30
AI to Accurately Predict Metastasis in Pancreatic Cancer Patients
Núria Malats, Madrid, Spain
17:30 - 17:50
PANcreatic Cancer Initial Detection via liquid biopsy
Matthias Löhr, Stockholm, Sweden
17:50 - 18:10
Does pancreatitis cause pancreatic cancer?
Santhi Swaroop Vege, Rochester, USA
09:15 - 09:30
Registration
08:30 - 18:30
Champalimaud Auditorium & Botton-Champalimaud Pancreatic Cancer Centre
09:15 - 09:30
IPMN
09:00 – 10:40
Botton Auditorium
Chairs:
- Luis Graça, Porto, Potugal
- Zipeng Lu, Nanjing, China
- André Mihaljevic, Tubingen, Germany
- Felix Nickel, Hamburg, Germany
09:00 - 09:20
Pathology of IPMN
Volkan Adsay, Istanbul, Turkey
09:20 - 09:40
Genomic Landscape
Anguraj Sadanandam, Lisbon, Portugal
09:40 - 10:00
Principles of Surgery for IPMN
Cristina Ferrone, Los Angeles, USA
10:00 - 10:20
Debate: Watch and Wait
Stefano Crippa, Milan, Italy
10:20 - 10:40
Debate: Surgery
Ana João, Lisbon, Portugal
09:15 - 09:30
Advanced Model Systems
09:00 – 11:00
Champalimaud Auditorium
Chairs:
- Giulia Biffi, Cambridge, UK
- Channing Der, North Carolina, USA
- William Hwang, Boston, USA
09:00 - 09:20
Defining and characterising the functional microenvironment of Pancreatic Cancer
Claus Jørgensen, Manchester, UK
09:20 - 09:40
Dissecting the role of copy number alterations in PDAC immune invasion
Francisco Barriga, Madrid, Spain
09:40 - 10:00
Closing the circle: ex vivo and in vivo engineering of focal gene amplifications
Andrea Ventura, New York, USA
10:00 - 10:20
Spatial perturbation screens uncover immune-evasive tumour niches in pancreatic cancer
Chiara Falcomatà, New York, USA
10:20 – 10:40
Deep learning and integration of multi-omics for better understanding the early evolution of pancreatic cancer
Ashley Kiemen, Baltimore, USA
10:40 - 11:00
Plasma whole genomes in pancreatic cancer
Faiyaz Notta, Toronto, Canada
09:15 - 09:30
ISGPS session*
09:00 – 11:00
Botton Seminar Room
Chairs:
- Christos Dervenis, Athens, Greece
- Jens Werner, Munich, Germany
- Christoph Wolfgang, New York, USA
09:00 - 09:20
Update ISGPS-PPH definition
Filipe Borges, Lisbon, Portugal
09:20 - 09:40
Update ISGPS-DGE definition
Marc Besselink, Amsterdam, Netherlands
09:40 - 10:00
PP-Diarrhea definition
Oliver Strobel, Vienna, Austria
10:00 - 10:20
PP-Mortality
Giovanni Marchegiani, Padova, Italy
10:20 - 11:00
Discussion
09:15 - 09:30
Coffee Break
10:40 - 11:30
09:15 - 09:30
Robotic Pancreatic Surgery
11:30 – 12:50
Botton Auditorium
Chairs:
- Safi Dokmak, Paris, France
- Michael Ghadimi, Berlin, Germany
- Emanuel Vigia, Lisbon, Portugal
- Jürgen Weitz, Dresden, Germany
11:30 - 11:50
Evidence based robotic surgery
Marc Besselink, Amsterdam, Netherlands
11:50 - 12:10
Robotic Surgery: Selection is Key
Nuh Rahbari, Ulm, Germany
12:10 - 12:30
Robotic Pancreatic Head Resection
Felix Nickel, Hamburg, Germany
12:30 - 12:50
Robotic Left Resection
Gil Gonçalves, Lisbon, Portugal
09:15 - 09:30
Advances in Pancreatic Cancer Oncology (1)
11:30 – 13:30
Champalimaud Auditorium
Chairs:
- Paulo Costa, Lisbon, Portugal
- Mariano Ponz-Sarvisé, Pamplona, Spain
- Kim Reiss, Philadelphia, USA
- Götz Richter, Stuttgart, Germany
11:30 - 11:50
Neoadjuvant Treatment
Carlos Carvalho, Lisbon, Portugal
11:50 - 12:10
Adjuvant Treatment
John Neoptolemos, Heidelberg, Germany
12:10 - 12:30
Immunotherapy
Elke Jäger, Frankfurt, Germany
12:30 - 12:50
Systemic treatment opportunities and challenges
Philip Philip, Detroit, USA
12:50 - 13:10
GemPred trials: predicting Gemcitabine sensitivity
Jérôme Cros, Paris, France
13:10 - 13:30
Update on PASS-1 trial: signature stratifications for treatment
Grainne O’Kane, Dublin, Ireland
09:15 - 09:30
Lunch
12:30 - 14:30
09:15 - 09:30
APP (Associação Portuguesa de Pâncreas) Session*
13:30 - 16:00
Botton Seminar Room
13:30 - 13:50
The Future of Pancreatology
Matthias Löhr, Stockholm, Sweden
Opening Session and National Perspectives
13:50 - 14:10
Introduction of the APP
Gil Gonçalves, Lisbon, Portugal
14:10 - 14:30
Current Overview of Pancreatic Diseases in Portugal: Challenges and Opportunities
Emanuel Vigia, Lisbon, Portugal
Future and Collaborations
14:30 - 14:50
Multicenter Research Initiatives and Collaboration Networks of the APP
Gil Gonçalves, Lisbon, Portugal
14:50 - 15:10
Pancreatic Cancer Diagnosis: Emotional Impact, Support and Survivorship
Luzia Travado, Lisbon, Portugal
15:10 - 15:30
Patient advocacy and research support initiatives in Pancreatic Cancer Europe - A multi-stakeholder platform supporting the pancreatic cancer community
Maria Luisa Pagano, Brussels, Belgium
15:30 - 16:00
Audience Discussion

09:15 - 09:30
Publishing for Impact
14:00 – 14:30
Champalimaud Auditorium
Chair:
- Markus Büchler, Lisbon, Portugal
14:00 - 14:30
How to Publish in the Best Journals
Keith Lillemoe, Boston, USA
09:15 - 09:30
Pancreatic surgery - minimally invasive and organ preserving
14:30 – 15:50
Botton Auditorium
Chairs:
- Christos Devernis, Athens, Greece
- Robert Grützmann, Erlangen, Germany
- Martin Loos, Heidelberg, Germany
- Oliver Strobel, Vienna, Austria
14:30 - 14:50
Resect the Unresectable
Jürgen Weitz, Dresden, Germany
14:50 - 15:10
Minimally Invasive Pancreatic Surgery
Ugo Boggi, Pisa, Italy
15:10 - 15:30
Periampullary Cancer
Francesco Di Mola, Chieti-Pescara, Italy
15:30 - 15:50
Organ Preserving Surgery
Jin He, Baltimore, USA
09:15 - 09:30
Advances in Pancreatic Cancer Oncology (2)
14:30 – 16:30
Champalimaud Auditorium
Chairs:
- Jérôme Cros, Paris, France
- Elke Jäger, Frankfurt, Germany
- Philip Philip, Detroit, USA
- Santhi Swaroop Vege, Rochester, USA
14:30 - 14:50
Developing a clinically viable MYC inhibitor: to boldly go where no one has gone before
Laura Soucek, Barcelona, Spain
14:50 - 15:10
Novel Insights and Therapies for BRCA-Related Pancreatic Cancer
Kim Reiss, Philadelphia, USA
15:10 - 15:30
Vaccination Strategies
Dirk Jäger, Heidelberg, Germany
15:30 - 15:50
Cell-based therapies for pancreatic cancer
Christoph Springfeld, Heidelberg, Germany
15:50 - 16:10
Targeting IL1beta in combination with chemotherapy in advanced and localized pancreatic cancer
Paul Oberstein, New York, USA
16:10 - 16:30
Therapeutic Strategies Targeting the TME in PDAC
Manuel Hidalgo, New York, USA
09:15 - 09:30
Coffee break
16:00 - 16:30
09:15 - 09:30
Surgery of Advanced Pancreatic Cancer
16:30 – 18:10
Champalimaud Auditorium
Chairs:
- Pierluigi Di Sebastiano, Chieti, Italy
- Markus Diener, Nürnberg, Germany
- Beat Müller, Basel, Switzerland
- Jorge Paulino, Lisbon, Portugal
16:30 - 16:50
Arterial Reconstruction
Christopher Wolfgang, New York, USA
16:50 - 17:10
Multivascular Resection
Philippe Bachellier, Strasbourg, France
17:10 - 17:30
Portal vein occlusion: is reconstruction always necessary?
Jens Werner, Munich, Germany
17:30 - 17:50
Venous Reconstruction Techniques
Giovanni Marchegiani, Padova, Italy
17:50 - 18:10
Portal Vein Arterialization
Arianeb Mehrabi, Heidelberg, Germany
09:15 - 09:30
PDAC Tumour microenvironment (2)
16:30 - 18:30
Botton Auditorium
Chairs:
- Corinne Bousquet, Toulouse, France
- Hartland Jackson, Toronto, Canada
- Nina Steele, Cincinnati, USA
- Sophie Vasseur, Marseille, France
16:30 - 16:50
Understanding and exploiting barriers to pancreatic tumorigenesis
Scott Lowe, New York, USA
16:50 - 17:10
Roles of fibroblasts in pancreatic cancer metastasis and cachexia
Giulia Biffi, Cambridge, UK
17:10 - 17:30
Rag GTPase signaling in myeloid cells links nutrient overload with inflammation and PDAC
Alejo Efeyan, Madrid, Spain
17:30 - 17:50
Epigenetic reprogramming of pancreatic cancer to leverage anti-PD1 immunotherapy
Silvestre Vicent, Pamplona, Spain
17:50 - 18:10
TNG961: Targeting HBS1L for the Treatment of Chr9p21 Deleted Cancers with FOCAD loss
Jannik Andersen, Boston, USA
18:10 - 18:30
The Role of Microbiome
Peter Malfertheiner, Munich, Germany
09:15 - 09:30
ESPAC session*
16:30 - 18:30
Botton Seminar Room
Chairs:
- Markus Büchler, Lisbon, Portugal
- John Neoptolemos, Heidelberg, Germany
16:30 - 16:40
ESPAC6 and 7 - Overview
Thomas Hank, Heidelberg, Germany
16:40 - 16:50
ESPAC6 - Update
Sabine Beck, Frankfurt, Germany
16:50 - 17:00
State of the Art - Treatment of Pancreatic Cancer
Christoph Springfeld, Heidelberg, Germany
17:00 - 17:10
The ESPAC signature - Quality control
Benedikt Brors, Heidelberg, Germany
17:10 - 17:20
Sample Logistics
Tessa Peccerella, Heidelberg, Germany
17:20 - 17:30
The ESPAC Translational Programme - Overview
Maximilian Reichert, Munich, Germany
17:30 - 17:40
The ESPAC Translational Programme - Role of the Tumor Microenvironment
Barbara Grünwald, Essen, Germany
17:40 - 17:50
The ESPAC Translational Programme - Decentralized Organoid Workflow and Co-culture Models
Daniel Öhlund, Umea, Sweden
17:50 - 18:00
ESPAC7 - Surgical Decision Making
Güntaç Uzunoğlu, Hamburg, Germany
18:00 - 18:30
Discussion
Welcome / Introduction
Advances in Pancreatic Cancer Treatment
Coffee Break
Advances in Pancreatic Cancer Treatment (Cont.)
Lunch Break
Cell plasticity and tumor heterogeneity
Developing Standards
International Study Group of Pancreatic Surgery (ISGPS)*
Coffee Break
Surgery vs wait and see: PanNET’s and IPMN
Surgery for Locally Advanced PDAC
09:15 - 09:30
Registration
08:00 - 13:30
Champalimaud Auditorium & Botton-Champalimaud Pancreatic Cancer Centre
09:15 - 09:30
Early Career Research Session
08:30 – 11:00
Botton Auditorium
Chairs:
- Direna Alonso-Curbelo, Barcelona, Spain
- Günter Schneider, Göttingen, Germany
- Rosalie Sears, Portland, USA
08:30 - 08:45
Würth sponsored talk - Pulsed priming with Narmafotinib enhances both Gemcitabine/Abraxane & FOLFIRINOX response in pancreatic cancer
Kendelle Murphy, Sydney, Australia
08:45 - 09:00
Würth sponsored talk - Global mapping of drug synergy landscapes through massively parallel Cas13d genetic interaction screening
Juan J. Montero, Munich, Germany
09:00 - 09:15
Würth sponsored talk - Targeting mutual dependence of PI3Kα/δ and SUMO signaling in pancreatic cancer
Matthias Wirth, Göttingen, Germany
09:15 - 09:30
Würth sponsored talk - Using pluripotent stem cell derived pancreatic organoids to model human pancreas organogenesis and disease
Jonathan Brassard, Cincinnati, USA
09:30 - 09:45
Würth sponsored talk - The RNA regulator HuR promotes pancreatic cancer liver metastasis through control of stress response pathways
Katherine Pelz, Oregon, USA
09:45 - 10:00
Würths ponsored talk- Uncovering Drug Resistance and Prognostic Biomarkers: Correlative Science Insights from the SPEAR and MoST-P Clinical Trials
Aparna Raina, Sydney, Australia
10:00 - 10:15
Würth sponsored talk - From Heterogeneity to Hope: Revisiting Pancreatic Cancer Treatment in the Era of Precision Oncology
Dana Mustafa, Rotterdam, Netherlands
10:15 - 10:30
PCUK sponsored talk - Pancreatic Cancer Initiation: Wnt Signalling and Cell Dormancy Enable Kras Mutant Cell Survival
Beatriz Salvador, Cardiff, UK
10:30 - 10:45
PCUK sponsored talk - Quiescent-like Cancer Cells Drive Immune Evasion and Therapeutic Resistance in Heterogeneous Pancreatic Ductal Adenocarcinoma
Yuta Ikami, Sutton, UK
10:45 - 11:00
PCUK sponsored talk - Transcription factor switching drives progression of the classical subtype of pancreatic cancer
Shalini Rao, Cambridge, UK
09:15 - 09:30
Breakout Session: Young Pancreatologists Forum*
09:00 – 10:30
Botton Seminar Room
Chairs:
- Filipe Borges, Lisbon, Portugal
- Thomas Hank, Heidelberg, Germany
09:00 - 09:10
The Role of Body Composition and Nutritional Status in Pancreatic Surgery
Miguel Fróis Borges, Lisbon, Portugal
09:10 - 09:20
Pancreatic surgery in Kyiv
Liudmyla Pererva, Kyiv, Ukraine
09:20 - 09:30
Tailoring the extent of resection in pancreatic surgery
Ingmar Rompen, Amsterdam, Netherlands
09:30 - 09:40
Body composition, patient-reported outcomes and a rationale for prehabilitation in pancreatic cancer patients
Louisa Bolm, Lubeck, Germany
09:40 - 09:50
Dynamic, risk-based drain management after pancreatoduodenectomy: reappraisal of early fistula predictors with and without transanastomotic stents
Giampaolo Perri, Padova, Italy
09:50 - 10:00
Pancreatic cancer in obese patients: metabolic disorder and tumor progression
Guangfu Wang, Nanjing, China
10:00 - 10:10
Reappraisal of the concept of timely surgery according to follow-up vs. upfront surgery strategy for Intraductal Papillary Mucinous Neoplasms
Riccardo Pellegrini, Colorado, USA
10:10 - 10:20
Decision Modeling to guide IPMN Management
Greg Sacks, New York, USA
10:20 - 10:30
Is there an optimal time interval for conversion surgery following preoperative chemotherapy?
Marionna Cathomas, Heidelberg, Germany
09:15 - 09:30
Surgery of Oligometastatic Pancreatic Cancer
09:00 – 10:40
Champalimaud Auditorium
Chairs:
- Jorge Daniel, Porto, Portugal
- Manuel Hidalgo, New York, USA
- Martin Schneider, Giessen, Germany
- Alessandro Zerbi, Milan, Italy
09:00 - 09:20
The German RCT
Michael Ghadimi, Gottingen, Germany
09:20 - 09:40
Indications for Surgery
Markus Diener, Nürnberg, Germany
09:40 - 10:00
Standards of surgical treatment
Oliver Strobel, Vienna, Austria
10:00 - 10:20
Liver after lung or both?
Pauli Puolakkainen, Helsinki, Finland
10:20 - 10:40
Surgery of peritoneal disease
Mohammed Al-Saeedi, Heidelberg, Germany
09:15 - 09:30
Coffee Break
10:40 - 11:30
09:15 - 09:30
Breakout Session: World Pancreas Forum - “The center effect”*
11:30 - 12:30
Botton Seminar Room
Chairs:
- Yi Miao, Nanjing, China
- Christoph Wolfgang, New York, USA
11:30 - 11:40
The Future of the WPF
Kasper Z'graggen, Bern, Switzerland
11:40 - 11:50
Caseload and Experience
Jishu Wei, Nanjing, China
11:50 - 12:00
Clinical Trials
Benedict Kinny-Köster, New York, USA
12:00 - 12:10
The Role of Research to Increase Quality
Filipe Borges, Lisbon, Portugal
12:10 - 12:20
The Learning Curve
Adrian Billeter, Basel, Switzerland
12:20 - 12:30
Better Quality with Bigger Teams
Ingmar Rompen, Heidelberg, Germany
09:15 - 09:30
Surgery of Pancreatic Cancer - final reflections
11:30 - 12:50
Champalimaud Auditorium
Chairs:
- Mohammed Al-Saeedi, Heidelberg, Germany
- Peter Malfertheiner, Munich, Germany
- Arianeb Mehrabi, Heidelberg, Germany
- Paul Oberstein, New York, USA
11:30 - 11:50
Multivascular resection: not much left unresectable
Markus Büchler, Lisbon, Portugal
11:50 - 12:10
Radicality of the Triangle Operation
André Mihajlevic, Tubingen, Germany
12:10 - 12:30
Portal Hypertension: bypass
Martin Loos, Heidelberg, Germany
12:30 - 12:50
Revolutionised Pancreatic Cancer Treatment – How to bring it to the patient
Beat Müller, Basel, Switzerland
09:15 - 09:30
Recurrence of Pancreatic Cancer
11:30 - 12:50
Botton Auditorium
Chairs:
- Christoph Berchtold, Heidelberg, Germany
- Gil Gonçalves, Lisbon, Portugal
- Giovanni Marchegiani, Padova, Italy
- Jens Werner, Munich, Germany
11:30 - 11:50
Predictive Factors of Early Recurrence
Elsa Francisco, Lisbon, Portugal
11:50 - 12:10
How to Prevent
Zipeng Lu, Nanjing, China
12:10 - 12:30
Radiotherapy
Inês Antunes, Lisbon, Portugal
12:30 - 12:50
Multivisceral and Complex Surgery
Safi Dokmak, Paris, France



